Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Antibody Drug Conjugates Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global Antibody Drug Conjugates Market

 

By Product Type (Kadcyla, Adcertis, Others), By Application (Leukemia, Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to2024

 

Global antibody drug conjugates market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Global Antibody Drug Conjugates Market

Antibody drug conjugates (ADCs) are novel targeted therapy drugs for the treatment of cancer. ADCs are composed of monoclonal antibodies attached to biologically active drugs by chemical linkers. They have targeting property of monoclonal antibodies combine with cancer cell killing of cytotoxic drugs. ADCs are examples of immunoconjugates and bioconjugates.

 

Market Dynamics: Global Antibody Drug Conjugates Market

Increase in prevalence of cancer due to change in lifestyle such as consumption of alcohol and tobacco around the globe is a key factor drives the global antibody drug conjugates market. Moreover, rise in R&D for the innovation of newer drugs, pipeline products under the various stages of clinical trials, grow in collaborations between the research institutes for oncology research, and raise in funding from the public and private sectors for R&D are anticipated to fuel the global antibody drug conjugates market. However, stringent regulations for the product approval, less number of existed drugs in the market, and high cost and adverse effects of products are expected to dampen the global antibody drug conjugates market.

 

Market Scope: Global Antibody Drug Conjugates Market

Antibody drug conjugates market is segmented on the basis of product type, application, and distribution channel

Based on the product type, the market is segmented into the following:

  • Kadcyla
  • Adcertis
  • Others

Based on the application, the market is segmented into the following:

  • Leukemia
  • Lymphoma

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Regional Analysis: Global Antibody Drug Conjugates Market

Geographically, global antibody drug conjugates market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America antibody drug conjugates market is poised to grow owing to rise in prevalence of various types of cancer, advancements in the newer cancer therapeutics by using nanotechnology, and recent FDA approval for the ADC molecules are anticipated to propel the market. Europe antibody drug conjugates market anticipated to offer lucrative opportunities due to increase in demand for antibody drug conjugate molecules, rise in R&D for the development of newer products, and presence of huge number of contract manufacturing companies. However, Asia Pacific antibody drug conjugates market is poised to grow at highest CAGR due to entry of market players into Asia Pacific countries, government support for the development of newer cancer therapeutics, and pipeline products.

 

Competition Assessment: Global Antibody Drug Conjugates Market

Some of the players in the global antibody drug conjugates market include:

  • Roche Holding AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Bayer HealthCare (Germany)
  • Progenics Pharmaceuticals (U.S.)
  • Roche Holding AG (Switzerland)
  • ImmunoGen, Inc. (U.S.)
  • Celldex Therapeutics (U.S.)
  • AbbVie Inc. (U.S.)
  • Millennium Pharmaceuticals (U.S.)
  • Agensys, Inc. (U.S.)

 

Notable Market Developments: Antibody Drug Conjugates Market

  • In September 2017, Pfizer, Inc. received FDA approval for the Mylotarg (Gemtuzumab Ozogamicin), and antibody drug conjugate used in newly diagnosed and relapsed or refractory CD33-Positive acute myeloid leukemia.

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  1. Table of Content
  2. Executive Summary
  3. Global Antibody Drug Conjugates Market Introduction
    • Global Antibody Drug Conjugates Market – Taxonomy
    • Global Antibody Drug Conjugates Market –Definitions
      • Product Type
      • Application
      • Distribution Channel
  1. Global Antibody Drug Conjugates Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Antibody Drug Conjugates Market Dynamic Factors – Impact Analysis
    • Global Antibody Drug Conjugates Market – Competition Landscape
    • Epidemiology
  2. Global Antibody Drug Conjugates Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Antibody Drug Conjugates Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Kadcyla
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Adcertis
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Antibody Drug Conjugates Market Forecast, By Application, 2013 – 2017 and Forecast, 2017 – 2024
    • Leukemia
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lymphoma
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Antibody Drug Conjugates Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Antibody Drug Conjugates Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel and Region, 2018 – 2024
  2. North America Antibody Drug Conjugates Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2018 – 2024
    • North America Antibody Drug Conjugates Market Dynamics – Trends
  3. Europe Antibody Drug Conjugates Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2018 – 2024
    • Europe Antibody Drug Conjugates Market Dynamics – Trends
  4. Asia-Pacific Antibody Drug Conjugates Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2018 – 2024
    • Asia-Pacific Antibody Drug Conjugates Market Dynamics – Trends
  5. Latin America Antibody Drug Conjugates Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2018 – 2024
    • Latin America Antibody Drug Conjugates Market Dynamics – Trends
  6. Middle East and Africa Antibody Drug Conjugates Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Kadcyla
      • Adcertis
      • Others
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Lymphoma
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Antibody Drug Conjugates Market – Opportunity Analysis Index, By Product Type, By Application, By Distribution Channel, and Country, 2018 – 2024
    • MEA Antibody Drug Conjugates Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Roche Holding AG (Switzerland)
      • Pfizer Inc. (U.S.)
      • Bayer HealthCare (Germany)
      • Progenics Pharmaceuticals (U.S.)
      • ImmunoGen, Inc. (U.S.)
      • Celldex Therapeutics (U.S.)
      • AbbVie Inc. (U.S.)
      • Millennium Pharmaceuticals (U.S.)
      • Agensys, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553